Log in
Enquire now
Ethris

Ethris

Provider of a proprietary RNA and lipidoid nanoparticle technology platform to discover, design and develop innovative therapies.

OverviewStructured DataIssuesContributors
Is a
Company
Company
Organization
Organization
B2X
B2B
B2B
CEO
‌
Carsten Rudolph
Legal Name
ethris GmbH
Company Operating Status
Active
Country
Germany
Germany
Crunchbase URL
crunchbase.com/organiz...ris-gmbh
CTO
‌
Christian Plank
Email Address
info@ethris.com
Founded Date
January 1, 2009
Founder
‌
Christian Plank
‌
Carsten Rudolph
Funding Round Date
January 1, 2022
Funding Round Amount (USD)
26,000,000
Funding Type
Series B
Series B
Headquarters
Munich
Munich
Industry
Biopharmaceutical
Biopharmaceutical
RNA
RNA
RNA-based and RNA-targeted therapeutics
RNA-based and RNA-targeted therapeutics
Engineering
Engineering
Biotechnology
Biotechnology
Biomedical engineering
Biomedical engineering
Health technology
Health technology
Investors
Bill & Melinda Gates Foundation
Bill & Melinda Gates Foundation
European Commission
European Commission
Latest Funding Round Date
May 6, 2025
Latest Funding Round Amount (USD)
11,000,000
Latest Funding Type
‌
Grant (money)
LinkedIn URL
@company/ethris-gmbh
Location
Germany
Germany
Number of Employees (Ranges)
51 – 200
Patents Assigned (Count)
12
Pitchbook URL
pitchbook.com/profiles.../58656-07
Total Funding Amount (USD)
11,000,000
Twitter URL
@ethris_mrna
Official Website
ethris.com

Find more companies like Ethris

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us